Pharmaceutical Processing Seals Global Market to Reach $2.79 Billion by 2026

The “Pharmaceutical Processing Seals Global Market Report 2022, By Type, Material, Application” report has been added to ResearchAndMarkets.com’s offering.

The global pharmaceutical processing seals market is expected to grow from $1.80 billion in 2021 to $2.03 billion in 2022 at a compound annual growth rate (CAGR) of 12.4%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $2.79 billion in 2026 at a CAGR of 8.3%.

The main types of pharmaceutical processing seals are O-rings, gaskets, lip seals, D seals, and others. O-ring seals are used to prevent leaks from pumps, valves, cylinders, and connectors used in pharmaceutical processing. The different materials include metals, PTFE, silicone, nitrile rubber, EPDM, others and are used in various applications such as manufacturing equipment, agitators, mixers, reactors, gear boxes, and others.

North America was the largest region in the pharmaceutical processing seals market in 2021. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The rise in chronic diseases is significantly contributing to the growth of the pharmaceutical processing seals market. Chronic diseases are defined as conditions that last more than a year and require ongoing medical care; they are global, national health issues that involve mortality and morbidity. These include heart disease, cancer, and diabetes.

The rise in chronic diseases is driving up demand for pharmaceuticals, which in turn is driving up demand for pharmaceutical processing seals. For instance, according to the International Diabetes Federation, in 2021, 537 million adults are suffering from diabetes worldwide, which is a huge increase as compared to 463 million adults living with diabetes in 2019.

Technological advancements are shaping the pharmaceutical processing seals market. Major companies operating in the pharmaceutical processing seals sector are focused on developing new technological solutions to meet consumer demand and strengthen their position.

For instance, in November 2021, Crawford Packaging, a UK-based packaging machines company launched Evolution S, the top seal packaging technology machinery with advanced tray sealing solution manufactured by Packaging Automation Ltd. Evolution S – Packing Automation has developed the world’s most efficient tray sealing technology, raising the bar for precision and fast sealing rates while decreasing the packaging area’s necessary footprint in a single lane configuration.

Markets Covered:

  1. By Type: O-rings; Gaskets; Lip seals; D seals; Others (Diaphragms and X-rings)
  2. By Material: Metals; PTFE; Silicone; Nitrile Rubber; EPDM; Others
  3. By Application: Manufacturing Equipment; Agitators; Mixers; Reactors; Gear Boxes; Others

Key Topics Covered:

1. Executive Summary

2. Pharmaceutical Processing Seals Market Characteristics

3. Pharmaceutical Processing Seals Market Trends And Strategies

4. Impact Of COVID-19 On Pharmaceutical Processing Seals

5. Pharmaceutical Processing Seals Market Size And Growth

6. Pharmaceutical Processing Seals Market Segmentation

7. Pharmaceutical Processing Seals Market Regional And Country Analysis

8. Asia-Pacific Pharmaceutical Processing Seals Market

9. China Pharmaceutical Processing Seals Market

10. India Pharmaceutical Processing Seals Market

11. Japan Pharmaceutical Processing Seals Market

12. Australia Pharmaceutical Processing Seals Market

13. Indonesia Pharmaceutical Processing Seals Market

14. South Korea Pharmaceutical Processing Seals Market

15. Western Europe Pharmaceutical Processing Seals Market

16. UK Pharmaceutical Processing Seals Market

17. Germany Pharmaceutical Processing Seals Market

18. France Pharmaceutical Processing Seals Market

19. Eastern Europe Pharmaceutical Processing Seals Market

20. Russia Pharmaceutical Processing Seals Market

21. North America Pharmaceutical Processing Seals Market

22. USA Pharmaceutical Processing Seals Market

23. South America Pharmaceutical Processing Seals Market

24. Brazil Pharmaceutical Processing Seals Market

25. Middle East Pharmaceutical Processing Seals Market

26. Africa Pharmaceutical Processing Seals Market

27. Pharmaceutical Processing Seals Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Pharmaceutical Processing Seals Market

29. Pharmaceutical Processing Seals Market Future Outlook and Potential Analysis

30. Appendix

Companies Mentioned

  • Trelleborg AB
  • Freudenberg Group
  • Flowserve Corporation
  • James Walker & Co.
  • Parker-Hannifin Corporation
  • Saint-Gobain S.A.
  • Garlock Sealing Technologies
  • John Crane
  • IDEX Corporation
  • Marco Rubber and Plastics
  • Technetics Group
  • Sealmatic
  • Maffs Seals Pvt. Ltd.
  • Quantech Sealing Systems
  • EagleBurgmann India Pvt. Ltd.

For more information about this report visit here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”